There are 2789 resources available
115P - Biomarkers in immune microenvironment for predicting the efficacy of immunotherapy with or without chemotherapy in non-small cell lung cancer (NSCLC)
Presenter: Rongjie Deng
Session: ePoster Display
66P - Leptin receptor (Ob-R) and its association with tumour infiltrating lymphocytes (TILs) in early breast cancer (BC): Correlation with pathological complete response (pCR)
Presenter: Laura García Estevez
Session: ePoster Display
67P - Homologous recombination deficiency in diverse cancer types and its correlation with platinum chemotherapy efficiency in ovarian cancer
Presenter: Hao Wen
Session: ePoster Display
125P - Cognitive impairment in breast cancer patients up to 18 months after cancer treatments: The French multicentric longitudinal CANTO-Cog cohort substudy
Presenter: Florence Joly Lobbedez
Session: ePoster Display
126P - Effects of GnRHa on ovarian function against chemotherapy-induced gonadotoxicity in premenopausal women with breast cancer in China: A prospective randomized controlled trial (EGOFACT)
Presenter: Xiangyun Zong
Session: ePoster Display
127P - The mutational landscape, oncogenic pathways and mutational signatures of breast neuroendocrine tumors
Presenter: Peeter Karihtala
Session: ePoster Display
128P - Characteristics, patterns of care and outcomes of young women with breast cancer (BC) according to age, year of diagnosis and germline BRCA status (gBRCA)
Presenter: Kevin Punie
Session: ePoster Display
129P - Integration of gene expression and tumor-infiltrating lymphocytes (TILs) to predict pCR after neoadjuvant chemotherapy and nivolumab for patients with luminal B-like breast cancer in the phase II GIADA trial
Presenter: Maria Vittoria Dieci
Session: ePoster Display
74P - A predictive signature for response to immunotherapy in non-small cell lung cancer based on plasma proteomics and clinical parameters
Presenter: Yuval Shaked
Session: ePoster Display